arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Kymera Therapeutics, Inc.

KYMR Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$74.13
▼ -0.6% Today
as of Jun 7, 07:19 ET
Last 30 days -11.59% Apr 28 → Jun 05
$70.09 $74.43 $78.78 $83.12 $87.46 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$74.36
High
$75.39
Low
$72.77
Volume
$632,017
Avg Vol
$765,888
Mkt Cap
$6.7B
P/E (TTM)
Beta
52w High
$103.00
52w Low
$36.65
Div Yield
Shares Out
$82M

Overview

52-week range
$37
$103
56% of range
Avg surprise (last 1)
+10.9%
Avg reaction (last 1)
-2.3%
0% positive
Latest IV / EM
67%
EM ±9.3% · $75 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.95$-0.86$-0.76$-0.67$-0.58 Actual $-0.67Actual $-0.90Actual $-0.69Actual $-0.58Actual $-0.82Actual $-0.82Est $-0.92Actual $-0.95Actual $-0.94Actual $-0.71 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$-82M$-53M$-23M$7M$36M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $-0.71 financials
Tue Sep 30, 2025Sep 2025 $-0.94 financials
Mon Jun 30, 2025Jun 2025 $-0.95 financials
Fri May 9, 2025Mar/2025 $-0.82 $-0.92 +10.9% -2.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.82 financials
Sun Jun 30, 2024Jun 2024 $-0.58 financials
Sun Mar 31, 2024Mar 2024 $-0.69 financials
Sat Sep 30, 2023Sep 2023 $-0.90 financials
Fri Jun 30, 2023Jun 2023 $-0.67 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$34M$3M$11M$22M$4M$26M
Cost of revenue$34M$3M$11M$22M$4M$26M
Gross profit
Operating income$-84M$-93M$-85M$-74M$-72M$-51M
Net income$-69M$-82M$-77M$-66M$-62M$-42M
EPS (diluted)$-0.71$-0.94$-0.95$-0.82$-0.82$-0.58

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$144M$357M$113M$336M$90M$120M$111M$68M
Inventory
Total current assets$677M$871M$528M$728M$501M$510M$569M$525M
Total assets$1.67B$1.74B$1.10B$1.13B$918M$978M$1.03B$826M
Long-term debt
Total liabilities$129M$163M$156M$160M$132M$142M$142M$141M
Total equity$1.54B$1.58B$946M$971M$786M$836M$893M$685M

Implied volatility — last 90 days

62%64%67%69%72% Jun 07 — IV 67% · EM ±9.3%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.